Core Insights - The company, Dao's Technology, has signed an investment agreement with the local government of Enping for a project to produce 1,000 tons of silicon-carbon anode materials annually, with an initial investment of 150 million yuan [3]. Group 1 - The project has received strong support and recognition from the local government, which will help the company enhance its industrial layout in solid-state battery materials and expand its business scale [3]. - Dao's Technology has made significant progress in the industrialization of silicon-carbon anodes, having collaborated with over 30 clients across consumer, digital, and power battery sectors, with some clients already achieving bulk shipments [3]. - The demand from downstream partners is rapidly increasing, and the company plans to expand the annual production capacity of the 1,000-ton project to 5,000 tons based on market demand [3]. Group 2 - Additionally, the company is constructing another production line with a capacity of 300 tons per year, which is expected to be operational by the end of 2025 to meet the growing demand [3].

硅碳负极材料项目是道氏技术一项重要的前瞻布局。今日(9月10日)，该项目正式迈向了产业化新征 程，道氏技术年产1000吨硅碳负极项目已和恩平当地政府部门签订项目投资协议，正积极推进项目落 地。项目的落地将有助于公司完善在固态电池材料方面的产业布局和扩大业务规模，为提升持续盈利能 力、强化综合实力奠定坚实的基础。 (原标题：道氏技术（300409）：年产1000顿硅碳负极项目与恩平政府签订投资协议) 据悉，道氏技术已与众多企业陆续开展评测和送样合作，至今累计向涵盖消费、数码和动力电池等领域 的30余家客户送样，其中部分客户已实现批量出货。 道氏技术表示，本次年产1000吨项目后续根据市场需求动态，可进一步扩大至年产5000吨。为及时有效 满足需求，道氏硅碳负极项目另有300吨年产能正在建设中，将于2025年年底率先落地。(文穗) ...

资料显示，广东道氏技术股份有限公司位于广东省佛山市禅城区南庄镇怡水三路1号1座，成立日期2007 年9月21日，上市日期2014年12月3日，公司主营业务涉及生产和销售建筑陶瓷的釉面材料,并提供相关 的技术服务和产品设计;商业保理业务;新能源材料。主营业务收入构成为：其他47.44%，锂电材料 34.70%，碳材料9.00%，陶瓷材料8.85%。 截至6月30日，道氏技术股东户数7.41万，较上期减少0.52%；人均流通股9273股，较上期增加3.51%。 2025年1月-6月，道氏技术实现营业收入36.54亿元，同比减少11.64%；归母净利润2.30亿元，同比增长 108.16%。 9月8日，道氏技术（维权）跌0.12%，成交额36.17亿元。两融数据显示，当日道氏技术获融资买入额 5.86亿元，融资偿还3.31亿元，融资净买入2.56亿元。截至9月8日，道氏技术融资融券余额合计16.86亿 元。 融资方面，道氏技术当日融资买入5.86亿元。当前融资余额16.80亿元，占流通市值的8.84%，融资余额 超过近一年90%分位水平，处于高位。 融券方面，道氏技术9月8日融券偿还200.00股，融券卖出2000 ...

Group 1: Industry Overview - The non-ferrous metal sector is experiencing significant activity, with various companies in the resource layout and high-end powder materials, as well as battery materials, seeing stock price increases [1] - Companies are focusing on the development of nickel resources and high-performance materials to capitalize on the growing demand in the battery sector [2] Group 2: Company Highlights - Boqian New Materials (605376.SS) achieved a 10.00% increase in stock price, reaching 48.72 yuan, and is recognized as a leading producer of high-end metal powder materials, particularly nickel powder for MLCC production [1] - Dao Technology (300409.SZ) saw an 8.84% rise in stock price to 24.02 yuan, expanding its overseas nickel resource layout and developing a high-nickel project in Indonesia with a planned annual output of 20,000 tons [1] - Changsheng Technology (300073.SZ) increased by 8.37% to 52.30 yuan, partnering with Zhongwei Co. to develop nickel resources in Indonesia, aiming for an initial production line of 60,000 tons of nickel products [2] - Dongfang Electric Heating (300217.SZ) rose 7.06% to 5.61 yuan, successfully entering the lithium battery material sector with a project producing 20,000 tons of pre-plated nickel [2] - Hanrui Cobalt (300618.SZ) increased by 6.61% to 46.30 yuan, establishing a joint venture in Indonesia to expand its presence in the new energy metal sector [2] - Xingye Silver Tin (000426.SZ) saw a 6.04% increase to 23.35 yuan, with significant nickel resource reserves of 32.84 million tons, providing a solid foundation for future expansion in the nickel industry [3]

Core Insights - The brain-computer interface (BCI) sector is experiencing a significant increase in investment and financing activities, with notable funding rounds completed by companies like Shanghai Brain Rhythm Technology and Guangdong Daoshi Technology [1][4] - The technology is advancing from conceptual applications to real-world uses, spanning various fields such as medical rehabilitation, treatment of neurological diseases, cognitive enhancement, and human-machine collaboration [2] - Government policies are actively promoting the BCI industry, with initiatives aimed at creating industrial clusters, establishing key laboratories, and facilitating clinical applications [3] Investment Trends - Investment enthusiasm in the BCI sector is on the rise, with a notable increase in financing activities in the first half of the year, surpassing the total number from the previous year [4] - Companies like Beijing Zhiran Medical Technology have successfully raised significant funds, indicating market confidence in the potential of invasive BCI technologies [5] Technological Advancements - BCI technology is breaking traditional interaction methods, allowing for direct interpretation of neural signals and seamless conversion from "thought" to "command," which enhances its applicability across various domains [2] - Key technological breakthroughs, such as flexible electrodes and wireless power supply, are expected to facilitate multi-scenario applications in healthcare, consumer electronics, and industrial manufacturing [5] Policy Support - Various regions in China, including Beijing and Shanghai, have launched specific action plans to support the BCI industry, aiming for high-quality development and comprehensive clinical application by 2030 [3] - The establishment of industry standards and inclusion of BCI surgeries in medical insurance coverage are steps towards creating a complete commercialization loop for BCI technologies [3]

证券代码：300409 证券简称：道氏技术 公告编号：2025-096 广东道氏技术股份有限公司 关于为子公司提供担保的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 特别风险提示： 广东道氏技术股份有限公司（以下简称"公司"）及其控股子公司对外担保 总额超过公司最近一期经审计净资产100%，前述担保均为公司合并范围内的担 保，担保风险可控，敬请投资者充分关注担保风险。 一、担保情况概述 公司于2025年4月22日召开第六届董事会2025年第7次会议、第六届监事会 2025年第5次会议，于2025年5月14日召开2024年年度股东大会，分别审议通过 了《关于2025年度公司及子公司向银行申请综合授信额度及为子公司提供担保 的议案》，同意公司为子公司提供合计不超过780,000.00万元担保额度，额度 有效期为自2024年年度股东大会审议通过之日起12个月。其中为芜湖佳纳能源 科技有限公司（以下简称"芜湖佳纳"）及其子公司提供不超过530,000.00万元的 担保额度；为佛山市格瑞芬新能源有限公司（以下简称"佛山格瑞芬"）及其子 公司提供不超过100, ...

Group 1 - The core viewpoint of the article is that Daoshi Technology's subsidiary, Hong Kong Jiana, has signed a Pre-B round preferred stock subscription agreement with Brain Family Inc., a leading brain-computer interface technology company, investing $30 million to acquire minority shareholder rights [1] - Brain Family Inc. has over 460 authorized patents and its core products have received multiple international certifications, including FDA and CE, indicating strong R&D capabilities and commercial applications in high-value fields such as medical rehabilitation, educational technology, consumer health, and human-computer interaction [1] - The investment aims to leverage opportunities in the AI era, enhancing the company's "AI + materials" strategy and improving its core competitiveness through collaboration with Brain Family Inc. in the application of carbon materials in areas like electronic skin [1] Group 2 - The preferred shares acquired by Hong Kong Jiana will have superior rights in liquidation, voting, and repurchase compared to common shares, and can be converted to common shares at a 1:1 ratio [1] - The pricing of the subscription was determined based on the industry characteristics, R&D strength, future potential of Brain Family Inc., and valuations from other investors in the Pre-B round [1]

Core Viewpoint - Guangdong Daoshi Technology Co., Ltd. announced its subsidiary Hong Kong Jian Na Limited plans to invest $30 million (approximately 213 million RMB) to acquire minority equity in Qiangnao Technology's Pre-B round preferred shares [1][4]. Company Overview - Qiangnao Technology, founded in February 2015 by Han Bicheng, focuses on the development of non-invasive brain-computer interface technology, which is safer and has a broader application range compared to invasive methods [3]. - The company relocated its headquarters to Hangzhou in 2018 and is part of a group of innovative tech firms known as the "Hangzhou Six Little Dragons" [3]. - Qiangnao Technology has launched several products, including smart bionic limbs and brain-machine intelligent sleep devices, indicating a shift from laboratory research to commercial application [3]. Investment Details - Daoshi Technology's investment in Qiangnao Technology aims to leverage the latter's experience in applying brain-computer interface technology in medical rehabilitation, education, and human-computer interaction, enhancing Daoshi's "AI + new materials" strategy [7]. - Qiangnao Technology is currently in the Pre-B round stage and has been rumored to be negotiating a pre-IPO financing of approximately $100 million at a valuation exceeding $1.3 billion, potentially paving the way for an IPO in Hong Kong or mainland China [5][4]. Financial Performance - Daoshi Technology reported a significant reduction in R&D expenses, down 41.39% year-on-year to 88.68 million RMB, attributed to decreased direct material inputs and personnel costs [9]. - The company’s revenue for the reporting period was approximately 3.65 billion RMB, reflecting an 11.64% decrease compared to the previous year [9]. Industry Context - The brain-computer interface industry, where Qiangnao Technology operates, is considered an emerging sector, with profitability expected to be achieved only after 2024 [10]. - Qiangnao Technology has raised over $1 billion in total funding since its inception, with a current valuation potentially reaching $5 billion [10].

Summary of the Conference Call for Dow's Technology Company and Industry Overview - **Company**: Dow's Technology - **Industry**: AI and Materials Science, specifically focusing on brain-machine interface technology and advanced materials for robotics and sensors [2][3] Core Points and Arguments - **Investment in Long Brain Technology**: Dow's Technology invested $30 million in Long Brain Technology, a leader in non-invasive brain-machine interface technology, founded by Dr. Han Bicheng from Harvard University [4] - **Strategic Goals**: The investment aims to enhance product development efficiency and iteration speed through AI capabilities, aligning with Dow's strategy to become a platform company integrating AI with materials [4] - **Role of New Peison**: New Peison is crucial in Dow's AI strategy, focusing on discovering new materials and enhancing existing ones, particularly in humanoid and special robots, and sensor materials [5] - **AI Chip Development**: New Peison specializes in computing chips, addressing complex AI problems that traditional methods struggle with, and has received recognition from experts in the field [6] - **Artificial Neural Networks**: These networks excel in solving complex problems that cannot be described by equations, such as language models and image recognition, primarily relying on GPU technology [7] Breakthroughs and Innovations - **Advancements in Computing**: New Peison achieved significant breakthroughs in addressing the "curse of dimensionality," improving speed and reducing power consumption in molecular dynamics and density functional theory calculations [8] - **APU Chip Applications**: The APU chip simulates the Schrödinger equation, applicable in various fields of materials science, including military, chemical, lithium battery, photovoltaic, semiconductor, and cosmetics [9][10] - **Future Development Plans**: New Peison plans to expand its technology applications to larger-scale problems, such as weather simulation and vehicle aerodynamics, by developing the EPU chip for high-speed, low-power calculations [11] Additional Important Insights - **Successful Transition**: Dow's Technology transitioned from a focus on ceramic ink materials to the renewable energy sector in 2018, leveraging AI opportunities for larger-scale development [12] - **Collaborative Strategy**: The collaboration with Long Brain Technology and other companies is part of a unified strategy of "AI + materials + applications," aiming for breakthroughs in new material development [5]

Group 1 - The core point of the article is that Dao's Technology announced the holding of its third extraordinary general meeting of shareholders for 2025 on September 3, 2025, to review and approve the proposal regarding the change of part of the fundraising purposes [2] Group 2 - The meeting was convened to discuss the adjustment of the use of raised funds, indicating a strategic shift in the company's financial management [2]